Baseline and clinical characteristics of patients with cardiogenic shock treated in hospitals with versus those without catheterisation facilities
| Facilities (n=186) | No facilities (n=68) | p Value | |
| Age (years) | 69.2 (12) | 73.7 (10) | 0.005 |
| Women | 68 (37%) | 35 (52%) | 0.03 |
| Medical history | |||
| Previous MI | 72 (39%) | 24 (35%) | 0.58 |
| Angina | 65 (35%) | 26 (38%) | 0.63 |
| Hypertension | 88 (47%) | 34 (50%) | 0.70 |
| Diabetes | 73 (39%) | 31 (46%) | 0.36 |
| Hyperlipidaemia | 36 (19%) | 8 (12%) | 0.16 |
| Smoking habit | 38 (20%) | 12 (18%) | 0.62 |
| Clinical features | |||
| Shock on admission1-151 | 94 (57%) | 34 (54%) | 0.91 |
| Time to shock (days) | |||
| Median | 0 | 0 | 0.78 |
| 25th–75th centile | 0–1 | 0–1 | |
| Anterior wall MI | 96 (52%) | 37 (54%) | 0.69 |
| Right ventricular MI | 24 (13%) | 7 (10%) | 0.55 |
| CPK level (U/l) | |||
| Median | 1422 | 1024 | 0.13 |
| 25th–75th centile | 690–2804 | 350–2072 | |
| Complications | |||
| Recurrent ischaemia | 17 (9%) | 4 (6%) | 0.40 |
| Recurrent MI | 13 (7%) | 5 (7%) | 0.92 |
| Atrial fibrillation | 39 (21%) | 15 (22%) | 0.85 |
| II°–III° AV block | 42 (23%) | 22 (32%) | 0.11 |
| VT/VF | 66 (35%) | 16 (23%) | 0.07 |
Values are n (%) or mean (SD).
↵1-151 Missing data for 27 patients.
AV, atrioventricular; CPK, creatine phosphokinase; MI, myocardial infarction; VF, ventricular fibrillation; VT, ventricular tachycardia.